<VariationArchive VariationID="832281" VariationName="NC_000009.12:g.(?_6533007)_(6610366_?)del" VariationType="Deletion" Accession="VCV000832281" Version="10" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820149" VariationID="832281">
      <GeneList>
        <Gene Symbol="GLDC" FullName="glycine decarboxylase" GeneID="2731" HGNC_ID="HGNC:4313" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6532467" stop="6645729" display_start="6532467" display_stop="6645729" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6532463" stop="6645691" display_start="6532463" display_stop="6645691" Strand="-" />
          </Location>
          <OMIM>238300</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.12:g.(?_6533007)_(6610366_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="6533007" innerStop="6610366" display_start="6533007" display_stop="6610366" variantLength="77360" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_6533007)_(6610366_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_6533007)_(6610366_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.12:g.(?_6533007)_(6610366_?)del AND Non-ketotic hyperglycinemia" Accession="RCV001032784" Version="9">
        <ClassifiedConditionList TraitSetID="3243">
          <ClassifiedCondition DB="MedGen" ID="C0751748">Non-ketotic hyperglycinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-03-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
                <XRef ID="Glycine+Encephalopathy/3115" DB="Genetic Alliance" />
                <XRef ID="237939006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycine encephalopathy</ElementValue>
                <XRef ID="MONDO:0011612" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
                <XRef ID="407" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonketotic hyperglycinemia</ElementValue>
                <XRef ID="HP:0008288" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NKH</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7219" />
                <XRef ID="7219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonketotic hyperglycinemia (NKH) is the inborn error of glycine metabolism defined by deficient activity of the glycine cleavage enzyme system (GCS), which results in accumulation of large quantities of glycine in all body tissues including the brain. Based on ultimate outcome NKH is categorized into severe NKH (no developmental progress and intractable epilepsy) and attenuated NKH (variable developmental progress and treatable or no epilepsy). The majority of children with NKH have onset in the neonatal period manifest as progressive lethargy evolving into profound coma and marked hypotonia; 85% have severe NKH and 15% attenuated NKH. Those with onset between two weeks and three months typically present with hypotonia; 50% have severe NKH and 50% attenuated NKH. Those with onset after age three months have attenuated NKH. Severe versus attenuated NKH is consistent within families, but the degree of developmental progress in those with attenuated NKH can vary.</Attribute>
                <XRef ID="NBK1357" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="407" DB="Orphanet" />
              <XRef ID="C0751748" DB="MedGen" />
              <XRef ID="MONDO:0011612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008288" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357346" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_000170.2_9_Deletion (exons 4-25)|MedGen:C0751748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196091" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly994Arg amino acid residue in GLDC. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID:¬†27362913). This suggests that this residue is clinically-significant, and that variants that disrupt this residue are likely to be disease-causing. A similar deletion has been reported in an individual affected with glycine encephalopathy¬†(PMID:¬†16601880). This variant is a gross deletion of the genomic region encompassing exons 4-25 of the GLDC gene. The 5' boundary is likely confined to intron 3. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLDC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(?_6533007)_(6610366_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357346" TraitType="Disease" MappingType="XRef" MappingValue="C0751748" MappingRef="MedGen">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

